- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10 Form of Perfomance Share Units Agreement for the 2012-2014 Performance Cyle
- 10 Form of Restricted Stock Units Agreement with Five Year Vesting
- 10 Form of Restricted Stock Units Agreement with Four Year Vesting
- 10 Form of Market Share Units
- 10 Senior Executive Severance Plan
- 12 Statement Re Computation of Ratios
- 21 Subsidiaries
- 23 Consent of Deloitte & Touche LLP
- 31 Section 302 Certification Letter
- 31 Section 302 Certification Letter
- 32 Section 906 Certification Letter
- 32 Section 906 Certification Letter
EXHIBIT 23.
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 33-33682, 33-62496, 333-114107, 333-117818 and 333-150471 on Form S-3, and Nos. 33-30856, 33-38411, 33-38587, 33-44788, 333-47403, 33-52691, 33-30756-02, 33-58187, 333-02873, 333-65424, 333-107414 and 333-144893 on Form S-8, of our reports dated February 17, 2012, relating to the consolidated financial statements of Bristol-Myers Squibb Company and subsidiaries (the “Company”) and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2011.
/s/ DELOITTE & TOUCHE LLP
Parsippany, New Jersey
February 17, 2012
E-23-1